Ghrelin promotes thymopoiesis during aging

Journal of Clinical Investigation

Volumn 117, Issue 10, 2007, Pages 2778-2790

  Dixit, Vishwa Deep ^a,b   Yang, Hyunwon ^a,b   Sun, Yuxiang ^c   Weeraratna, Ashani T ^a   Youm, Yun Hee ^b   Smith, Roy G ^c   Taub, Dennis D ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; LEPTIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; THYMOCYTE; THYMUS;

AGING; ANIMALS; GHRELIN; LEPTIN; MICE; MICE, MUTANT STRAINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, GHRELIN; T-LYMPHOCYTES; THYMUS GLAND;

EID: 34948853362     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30248     Document Type: Article

References (58)

1. Taub, D.D., and Longo, D.L. 2005. Insights into thymic aging and regeneration. Immunol. Rev. 205:72-93.
2. Linton, P.E., and Dorshkind, K. 2004. Age related changes in lymphocyte development and function. Nat. Immunol. 5:133-139.
3. Haynes, L., Eaton, S.M., Burns, E.M., Randall, T.D., and Swain, S.L. 2005. Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen. J. Exp. Med. 201:845-851.
4. Weng, N.P. 2006. Aging of the immune system: how much can the adaptive immune system adapt? Immunity. 24:495-499.
5. Hale, J.S., Boursalian, T.E., Turk, G.L., and Fink, P.J. 2006. Thymic output in aged mice. Proc. Natl. Acad. Sci. U. S. A. 103:8447- 8452.
6. Bhandoola, A., and Sambandam, A. 2006. From stem cell to T cell: one route or many? Nat. Rev. Immunol. 6:117-126.
7. Min, H., Montecino-Rodriguez, E., and Dorshkind, K. 2004. Reduction in the developmental potential of intrathymic T cell progenitors with age. J. Immunol. 173:245-250.
8. Kojima, M., et al. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656-660.
9. Smith, R.G. 2005. Development of growth hormone secretagogue. Endocr. Rev. 26:346-360.
10. Kojima, M., and Kengawa, K. 2005. Ghrelin: structure and function. Physiol. Rev. 85:495-522.
11. Gnanapavan, S., et al. 2002. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87:2988-2991.
12. Dixit, V.D., et al. 2004. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114:57-66. doi:10.1172/JCI200421134.
13. Dixit, V.D., and Taub, D.D. 2005. Ghrelin and immunity: a young player in an old field. Exp. Gerontol. 40:900-910.
14. Li, W.G., et al. 2004. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation. 109:2221-2226.
15. Granado, M., Priego, T., Martin, A.I., Villanua, M.A., and Lopez-Calderon, A. 2005. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am. J. Physiol. Endocrinol. Metab. 288:E486-E492.
16. Gonzalez-Rey, E., Chorny, A., and Delgado, M. 2006. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 130:1707-1720.
17. Chang, L., et al. 2005. Therapeutic effects of ghrelin on endotoxic shock in rats. Eur. J. Pharmacol. 473:171-176.
18. Sempowski, G.D., et al. 2000. Leukemia inhibitory factor, oncostatin M, IL-6 and stem cell factor mRNA expression in human thymus increases with age and are associated with thymic atrophy. J. Immunol. 164:2180-2187.
19. van den Brink, M.R., Alpdogan, O., and Boyd, R.L. 2004. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat. Rev. Immunol. 4:856-867.
20. Hakim, F.T., et al. 2005. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 115:930-939. doi:10.1172/JCI200522492.
21. Heng, T.S., et al. 2005. Effects of castration on thymocyte development in two different models of thymic involution. J. Immunol. 175:2982-2993.
22. Marchetti, B., et al. 1989. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology. 125:1037-1045.
23. Dixit, V.D., Sridaran, R., Edmonsond, M.A., Taub, D., and Thompson, W.E. 2003. Gonadotropin-releasing hormone attenuates pregnancy-associated thymic involution and modulates the expression of antiproliferative gene product prohibitin. Endocrinology. 144:1496-1505.
24. Sutherland, J.S., et al. 2005. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol. 175:2741-2753.
25. Murphy, W.J., Durum, S.K., and Longo, D.L. 1992. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J. Immunol. 149:3851-3857.
26. French, R., et al. 2002. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology. 143:690-699.
27. Montecino-Rodriguez, E., Clark, R., and Dorshkind, K. 1998. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology. 139:4120-4126.
28. Koo, G.C., et al. 2001. Immune enhancing effect of a growth hormone secretagogue. J. Immunol. 166:4195-4201.
29. Akiyama, T., et al. 2005. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science. 308:248-251.
30. Gray, D.H., et al. 2006. Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood. 108:3777-3785.
31. Andrew, D., and Aspinall, R. 2002. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp. Gerontol. 37:455-463.
32. Howard, J.K., et al. 1999. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 104:1051-1059.
33. Hick, R.W., et al. 2006. Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J. Immunol. 177:169-176.
34. Gray, D.H., et al. 2005. Controlling the thymic microenvironment. Curr. Opin. Immunol. 17:137-143.
35. Douek, D.C., et al. 1998. Changes in the thymic function with age and during the treatment of HIV infection. Nature. 396:690-695.
36. Nikolich-Zugich, J., Slifka, M.A., and Messaoudi, I. 2004. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4:123-132.
37. Naylor, K., et al. 2005. The influence of age on T cell generation and TCR diversity. J. Immunol. 174:7446-7452.
38. Lind, E.F., Prockop, S.E., Porritt, H.E., and Petrie, H.T. 2001. Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. J. Exp. Med. 194:127-134.
39. Zuniga-Pflucker, J.C. 2004. T-cell development made simple. Nat. Rev. Immunol. 4:67-72.
40. Phillips, J.A., et al. 2004. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J. Immunol. 173:4867-4874.
41. Bhandoola, A., and Sambandam, A. 2006. From stem cell to T cell: one route or many? Nat. Rev. Immunol. 6:117-126.
42. von Freeden-Jeffry, U., et al. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-1525.
43. Chu, Y.W., et al. 2004. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood. 104:1110-1119.
44. Nasi, M., et al. 2006. Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. Aging Cell. 5:167-175.
45. Li, L., et al. 2004. IL-12 inhibits thymic involution by enhancing IL-7- and IL-2-induced thymocyte proliferation. J. Immunol. 172:2909-2916.
46. Mokyr, M.B., Prokhorova, A., Rubin, M., and Bluestone, J.A. 1994. Insight into the mechanism of TCR-V beta 8+/CD8+ T cell-mediated MOPC-315 tumor eradication. J. Immunol. 153:3123-3134.
47. Dixit, V.D., et al. 2006. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J. Biol. Chem. 281:16681-16690.
48. Sarzotti, M., et al. 2003. T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation. J. Immunol. 170:2711-2718.
49. Pied, S., et al. 1997. Evidence for superantigenic activity during murine malaria infection. Int. Immunol. 9:17-25.
50. Sun, Y., Ahmed, S., and Smith, R.G. 2003. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23:7973-7981.
51. Sun, Y., Wang, P., Zheng, H., and Smith, R.G. 2004. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U. S. A. 101:4679-4684.
52. Zigman, J.M., et al. 2005. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 115:3564-3572. doi:10.1172/JCI26002.
53. Wortley, K.E., et al. 2005. Absence of ghrelin protects against early-onset obesity. J. Clin. Invest. 115:3573-3578. doi:10.1172/JCI26003.
54. Min, D., et al. 2007. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood. 109:2529-2537.
55. Zhao, H., and Liu, G. 2006. Growth hormone secretagogue receptor antagonists as anti-obesity therapies? Still an open question. Curr. Opin. Drug Discov. Devel. 9:509-515.
56. Zorrilla, E.P., et al. 2006. Vaccination against weight gain. Proc. Natl. Acad. Sci. U. S. A. 103:13226-13231.
57. Diano, S., et al. 2006. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9:381-388.
58. Kojima, M., and Kangawa, K. 2006. Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone. Nat. Clin. Pract. Endocrinol. Metab. 2:80-88.